Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole SodiumCategory 1.1 Ne...

HONG KONG, 17 July 2013 – Sihuan Pharmaceutical Holdings Group Ltd. announced that Anaprazole Sodium, a Category 1.1 new drug received the Approval for Clinical Studies from the State Food and Drug Administration (“SFDA”) of the People’s Republic...

Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole SodiumCategory 1.1 New Drug Clinical Studies
2014-06-30
Congrats to Beijing Sihuan Pharm for Ranking in the Top 100 Chinese Pharmaceutical Companies 2013

The 31st National Pharmaceutical Industry Information Annual Conference 2014, which was convened in Qingdao on June 28, 2014, announced the Top 100 Chinese Pharmaceutical Companies in 2013. Beijing Sihuan Pharmaceutical Co., Ltd., was ranked the 37th among the Top 100.

2014-06-20
Congrats to Beijing Sihuan Pharm for Winning the Hundred Fastest Growing Enterprises within State Hi-Tech Zones of Year

In May 2014, Beijing Sihuan Pharm was honored the “Hundred Fastest Growing Enterprises within State Hi-Tech Zones” of Year 2013 in recognition of its remarkable growth rate on top of its annual business scale.

2014-06-06
Notices - (Replacement of Lost Share Certificates)

Notices - (Replacement of Lost Share Certificates)

2014-05-28
Langfang Gaobo Jingband Successfully Passed FDA’s On-site Inspection

Langfang Gaobo Jingband Pharmaceutical has successfully passed the on-site inspection conducted by U.S. Food and Drug Administration (FDA)

2014-05-23
Congrats to Beijing Sihuan Pharm for Winning the “Beijing Trustworthy Enterprises of 2013”

Beijing Sihuan Pharm was honored the “Beijing Trustworthy Enterprises 2013” and received the Certificate of Honor and the Medal issued by Beijing Pharmaceutical Profession Association.

Total 6 Pages  First page  Page up  Page down  Last page

Select

  • 2014
  • 2013
  • 2012